MétaCan
Menu
Back to cohort
Record W3033542474 · doi:10.1167/tvst.9.7.2

Advancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano Symposium

2020· review· en· W3033542474 on OpenAlexaff
Debra A. Thompson, Alessandro Iannaccone, Robin R. Ali, Vadim Y. Arshavsky, Isabelle Audo, James Bainbridge, Cagri G. Besirli, David G. Birch, Kari Branham, Artur V. Cideciyan, Steven P. Daiger, Deniz Dalkara, Jacque L. Duncan, Abigail T. Fahim, John G. Flannery, Roberto Gattegna, John R. Heckenlively, Elise Héon, Thiran Jayasundera, Naheed W. Khan, Henry Klassen, Bart P. Leroy, Robert S. Molday, David C. Musch, Mark E. Pennesi, Simon M. Petersen‐Jones, Eric A. Pierce, Rajesh C. Rao, Thomas A. Reh, José‐Alain Sahel, Dror Sharon, Paul A. Sieving, Enrica Strettoi, Paul Yang, David N. Zacks

Bibliographic record

VenueTranslational Vision Science & Technology · 2020
Typereview
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRetinal Development and Disorders
Canadian institutionsUniversity of British ColumbiaHospital for Sick Children
FundersSpark TherapeuticsProQR TherapeuticsBiogenStrongNational Eye InstituteAstellas PharmaMedical Research CouncilNightstaRxAllerganResearch to Prevent Blindness
KeywordsClinical trialMedicineRetinalOphthalmologyOptometryBioinformaticsBiologyPathology

Abstract

fetched live from OpenAlex

Major advances in the study of inherited retinal diseases (IRDs) have placed efforts to develop treatments for these blinding conditions at the forefront of the emerging field of precision medicine. As a result, the growth of clinical trials for IRDs has increased rapidly over the past decade and is expected to further accelerate as more therapeutic possibilities emerge and qualified participants are identified. Although guided by established principles, these specialized trials, requiring analysis of novel outcome measures and endpoints in small patient populations, present multiple challenges relative to study design and ethical considerations. This position paper reviews recent accomplishments and existing challenges in clinical trials for IRDs and presents a set of recommendations aimed at rapidly advancing future progress. The goal is to stimulate discussions among researchers, funding agencies, industry, and policy makers that will further the design, conduct, and analysis of clinical trials needed to accelerate the approval of effective treatments for IRDs, while promoting advocacy and ensuring patient safety.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.084
metaresearch head score (Gemma)0.069
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.084
Threshold uncertainty score0.444

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0840.069
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.006
Bibliometrics0.0050.004
Science and technology studies0.0010.004
Scholarly communication0.0070.010
Open science0.0050.005
Research integrity0.0180.025
Insufficient payload (model declined to judge)0.0060.008

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.085
GPT teacher head0.453
Teacher spread0.368 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations92
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueTranslational Vision Science & TechnologySame topicRetinal Development and DisordersFrench-language works237,207